
Bariendo and Fractyl Health Plan for Potential GLP-1 Off-Ramp Program Pending FDA Approval of Revita
Bariendo and Fractyl Health partner to prepare for potential GLP-1 off-ramp program with investigational Revita pending FDA approval

Co-founder, CEO